Cambridge Healthtech Institute to Hold Inaugurual Next-Generation Pathology Symposia

Cambridge Healthtech Institute to Hold Inaugurual Next-Generation Pathology Symposia at 19th International Molecular Med Tri-CON 2012.
 
Jan. 5, 2012 - PRLog -- Next-Generation Pathology: Integrating Tools and Solutions for Tissue Analysis
February 19-20, 2012 | San Francisco, CA | Part of the Molecular Med Tri-Con

Next-generation sequencing, digital pathology and other innovative technologies are rapidly transforming the field of pathology and tissue analysis. Along with these technological advances, we are also witnessing an expansion in pathology applications, both in the pharmaceutical industry and research, and in the clinic. This symposium is designed to bring together pathologists and tissue analysis specialists working in the industry as well as in academic settings. The program will present solutions and case studies for various tissue analysis applications and will feature an array of novel technologies.

Keynote Presentation: Next-Generation Pathology: Possible Paths
Carlos Cordon-Cardo, M.D., Ph.D., Irene Heinz Given and John LaPorte Given Professor and Chairman, Department of Pathology, Professor, Department of Genetics and Genomic Sciences, The Mount Sinai School of Medicine; Professor and Director, Department of Pathology, The Mount Sinai Hospital

Presentations Include:

Development of Next-Generation Sequencing as a Clinical Test and Requirements for Laboratory Standards
Aziz, Ph.D., Director, Molecular Medicine, Transformation Program Office, College of American Pathologists

Clinical Interpretation of Next-Generation Sequencing Tests: A Whole New World
Wayne W. Grody, M.D., Ph.D., Professor, Divisions of Medical Genetics and Molecular Pathology, Departments of Pathology & Lab. Medicine, Pediatrics, and Human Genetics, Director, Diagnostic Molecular Pathology Laboratory, University of California, Los Angelas School of Medicine

Molecular is Nifty...Experiences Trying to Keep it Thrifty?
Jeffrey A. Kant, M.D., Ph.D., Director, Division of Molecular Diagnostics, University of Pittsburgh Medical Center Health System

Opportunities and Challenges of Molecular Diagnostics and Personalized Cancer Therapy
Dongfeng (Dan) Tan, M.D., Full Professor, Pathology and Laboratory Medicine, MD Anderson Cancer Center

Transformative Systems Pathology: Moving Omics to Clinics
Michael Roehrl, M.D., Assistant Professor, Pathology and Laboratory Medicine, Boston Medical Center

Bringing Biobanks to Life: Rapid and Highly Efficient Generation of Cell Lines from Pathology Specimens
Richard Schlegel, M.D., Ph.D., Professor and Chair, Pathology, Georgetown University Medical School

Next-Generation Pre-Clinical Xenograft Models
Yuzhuo Wang, Ph.D., Associate Professor, Urologic Science, University of British Columbia

Translational Pathology Research: The Quest for Predictive BioMarkers
Suzanne K. Coberly, M.D., FCAP, Pathologist Director, Amgen

Quantification and Standardization of in situ Measurement of Biomolecules in Formalin Fixed Paraffin Embedded Tissue
David L. Rimm, M.D., Ph.D., Professor of Pathology; Director, Medical Studies; Director, Pathology Tissue Services, Yale School of Medicine

Power of the Taqman Protein Assay (TPA) for Quantitative Protein Determination in Pathological Samples
Leendert Looijenga, Professor & Head, Laboratory Experimental Patho-Oncology, Pathology, Erasmus Medical Center

PANEL DISCUSSION: Molecular Pathology as the Driving Force for Precision Medicine
Moderator: Richard Levenson, M.D., Brighton Consulting Group

Multiplexing in Pathology: How Far Can We Go?
Richard Levenson, M.D., Brighton Consulting Group

Exome Sequencing for Candidate Gene Discovery in Inherited Disorders
Karl V. Voelkerding, M.D., Professor of Pathology, University of Utah; Medical Director, Genomics and Bioinformatics, ARUP Laboratories

Biomarker Discovery by NexGen Sequencing of Immune Repertoire
Jian Han, M.D., Ph.D., Faculty Investigator, R10K, HudsonAlpha Institute for Biotechnology

Leveraging the Power of Digital Pathology in Translational Research
Mark Lloyd, M.S., Staff Scientist, Analytic Microscopy, H. Lee Moffitt Cancer Center
Marilyn Bui, M.D., Ph.D., Associate Professor and Director, Anatomic Pathology and Analytic Microscopy, H. Lee Moffitt Cancer Center

Automated Feature Classification and Image-Based Feature Search in Whole Slide Image Data Sets
Ulysses G.J. Balis, M.D., Associate Professor and Director, Division of Pathology Informatics, University of Michigan

High Resolution Pathology for Personalized Medicine Using Automated Image Analysis Algorithms
Raj Bandaru, Associate Director, Informatics and Statistics Operations, Oncology Translational Laboratories, Novartis Pharmaceuticals

For more information visit triconference.com/next-generation-pathology

# # #

Since 1992, Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.
End
Source: » Follow
Email:***@healthtech.com Email Verified
Zip:02494
Tags:Pathology, Sequencing, Diagnostics, Biobanking, Tissue Assays, Biomarkers
Industry:Science, Technology, Biotech
Location:Needham - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share